3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
21
Recurrence
2
Smoldering Multiple Myeloma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm, Residual
1
Natural Killer/T-cell Lymphoma
1
Hematologic Neoplasms
1
Interventions
Dexamethasone
7
Bortezomib
6
Cyclophosphamide
5
daratumumab
3
Specimen Handling
3
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
3
venetoclax
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
belantamab mafodotin
2
auricularum
2
X-Rays
2
Phantoms, Imaging
2
Magnetic Resonance Spectroscopy
2
Clinical Protocols
2
Calcium Dobesilate
2
Biopsy
2
ixazomib
1
Tissue Banks
1
Stem Cell Transplantation
1
Pharmaceutical Preparations
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
isatuximab
×
90 days
×
Clear all
No trials found.